Publications of U. Reichl

Genzel, Y.; Best, C.; Behrendt, I.; König, S.; Sann, H.; Bock, A.; Reichl, U.: Optimization & Scale-up of Bioprocesses: Influenza Vaccine Production in Microcarrier Systems. Bioengineering Course (BEC), Supetar, Croatia (2003)

Hundt, B.; Reichl, U.: Comparing wave and stirred-tank bioreactor performance for vaccine production with feline lung fibroblasts. 11th Congress on biotechnology, Basel, Switzerland (2003)

Hundt, B.; Reichl, U.; Schänzler, A.: Serum-free cultivation of CEF for vaccine production in microcarrier-systems. 18th ESACT Meeting, Granada, Spain (2003)

Möhler, L.; Bock, A.; Sann, H.; Reichl, U.: Mathematical Modeling of MDCK Cell Growth by the Use of On-line Data. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)

Sann, H.; Bock, A.; Reichl, U.: Investigation of a new, sterile, deadvolume free sampling-system for universal applications, automated and suitable for online-analyzing. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)

Schmidt, J. K.; König, B.; Reichl, U.: Cooperation and competition: studies on heterogeneous microbial cultures. Jahrestagung der Vereinigung für allgemeine und angewandte Mikrobiologie (VAAM), Berlin, Germany (2003)

Sidorenko, Y.; Sann, H.; Reichl, U.: Structured model of Influenza virus replication in MDCK cells. 11th Congress on biotechnology, Basel, Switzerland (2003)

Genzel, Y.; Reichl, U.: Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. IUMS 2002, Paris, France (2002)

Genzel, Y.; Reichl, U.: Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. GVC/Dechema Jahrestagungen 2002, Wiesbaden, Germany (2002)

Genzel, Y.; Voges, L.; Reichl, U.: Development of bioprocess concepts on vaccine production: influenza virus as an example. 17th ESACT Meeting, Tyloesand, Sweden (2001)

Grabherr, R.; Reichl, U. (Eds.): Vaccine Biotechnology (Special issue). Biotechnology Journal 10, (5) (2015)

Rapp, E.; Reichl, U.: Preface to Advances in Glycobiotechnology. Advances in Glycobiotechnology, pp. i - vi (2021)

Grabherr, R.; Reichl, U.: Can modern vaccine technology pursue the success of traditional vaccine manufacturing? Biotechnology Journal 10 (5), pp. 657 - 658 (2015)

Kupke, S. Y.; Frensing, T.; Zmora, P.; Reichl, U.: Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use. US 2020/0392504A1 (2020)

Tapia, F.; Genzel, Y.; Reichl, U.: Plug Flow Tubular Bioreactor , System Containing the same and Method for Production of Virus. US 20190119616A1 (2019)

Wolff, M. W.; Pieler, M.; Reichl, U.; Marichal-Gallardo, P.: Method for the Separation of Virus Compositions Including Depletion and Purification thereof. US 20190085300A1 (2019)

Hellwig, P.; Dittrich, A.; Heyer, R.; Reichl, U.; Benndorf, D.: Detection, isolation and characterisation of phage-host complexes using BONCAT and click chemistry. bioRxiv (2024)

Karsten, C. B.; Buettner, F. F. R.; Cajic, S.; Nehlmeier, I.; Roshani, B.; Klippert, A.; Sauermann, U.; Stolte-Leeb, N.; Reichl, U.; Gerardy-Schahn, R. et al.; Rapp, E.; Stahl-Hennig, C.; Pöhlmann, S.: Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. bioRxiv (2024)

Zuniga-Banuelos, F. J.; Lemke, G.; Hoffmann, M.; Reichl, U.; Rapp, E.: Immunoglobulin A Carries Sulfated N glycans Primarily at the Tailpiece Site – An Oxonium-Ion-Guided Approach for Site-Specific N glycan Identification. bioRxiv (2024)

Zuniga-Banuelos, F. J.; Hoffmann, M.; Reichl, U.; Rapp, E.: New avenues for human blood plasma biomarker discovery via improved in-depth analysis of the low-abundant N glycoproteome. bioRxiv (2023)